Patent intelligence · US
US 8470344
Aqueous dispersions and solutions of difficult to dissolve materials and methods of their preparation
Aqueous dispersions and solutions of difficult to dissolve materials and methods of their preparation
Patent details — US 8470344
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 25, 2013
- Expiration
- Jun 20, 2033
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Claims
- 17
- CPC classes
- A61K, A61K31/557, A61K47/02, A61K47/186
Quick answer
US 8470344 (Aqueous dispersions and solutions of difficult to dissolve materials and methods of their preparation) is held by TEVA PHARMACEUTICAL INDUSTRIES, LTD.. Status: granted. Granted Jun 25, 2013. Expires Jun 20, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Expiration
- Claims
- 17
- CPC classes
- A61K, A61K31/557, A61K47/02, A61K47/186, A61K9/0048, A61K9/08
More from TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Related pharmaceutical patents in our USPTO index.
-
US 12310929
Use of rasagiline for the treatment of restless legs syndrome
granted -
US 12258401
Anti-CD47 combination therapy
granted -
US 12157729
Solid state forms of Belumosudil and Belumosudil salts
granted -
US 12139528
Treating refractory migraine
granted -
US 12091388
Solid state forms of Reproxalap
granted -
US 11826322
Pre-filled syringe
granted -
US 11813359
Sustained release olanzapine formulations
granted -
US 11773083
Solid state forms of Belumosudil and Belumosudil salts
granted
Related coverage
BBSW AI Solution: Key Insights from the 2026 Event
The BBSW AI Solution event in Foster, USA, promises to unveil critical advancements in AI technology for the pharma industry. Stay tuned for live updates and key takeaways.
BBSW AI Solution 2026: Key Insights and Highlights
The BBSW AI Solution event in 2026 is set to unveil groundbreaking advancements in AI technology. Join us for live coverage and key insights from industry leaders.
Frequently asked questions
What is US patent 8470344?
US 8470344 (Aqueous dispersions and solutions of difficult to dissolve materials and methods of their preparation) is held by TEVA PHARMACEUTICAL INDUSTRIES, LTD.. Status: granted. Granted Jun 25, 2013. Expires Jun 20, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8470344?
TEVA PHARMACEUTICAL INDUSTRIES, LTD. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 454 pharmaceutical patents for this assignee.
When does US 8470344 expire?
Our index shows an expiration date of Jun 20, 2033 (7 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.